MWMartin John Walshaw

Martin John Walshaw

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martin John Walshaw has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cystic Fibrosis Related Diabetes

    by Paula Dyce, Gareth Huw Jones, Martin J. Walshaw

    Cystic fibrosis related diabetes (CFRD) is a common co-morbidity of cystic fibrosis. It is associated with diminishing lung function, poorer nutritional state, and a worse prognosis and its early diagnosis and treatment is important. In addition, the adverse pulmonary effects of CFRD may be present for up to 10 years prior to diagnosis. Prevalence increases with age from 1 to 2% below 10 years of age, 20% of adolescents and 40-50% by adulthood, and up to 90% of adults with CF will have some degree of glucose intolerance by 40 years of age. Although its pathophysiology is not well understood, the primary cause is thought to be the fatty infiltration of the pancreas leading to fibrosis and destruction of the pancreatic cells resulting in beta cell destruction and progressive insulin deficiency. Oral glucose tolerance testing (OGTT) remains the method of choice for a diagnosis of type I, type II and gestational diabetes; it is less discriminating in CFRD where early glucose trends are important, and continuous glucose monitoring may prove a more useful diagnostic and management tool. Diabetic complications occur in CFRD and annual screening for these is necessary. As life expectancy rises, diabetic complications may become more prevalent. This chapter discusses the diagnosis and treatment of CFRD and touches on developments in research which will enhance the future management of this increasingly common and important manifestation of the CF condition.


  • Open Access

    Coming of age in cystic fibrosis – transition from paediatric to adult care

    by Dilip Nazareth, Martin Walshaw

    Cystic fibrosis (CF) is the most common multi-system inherited disorder, with a UK population exceeding 9,000. There have been significant improvements in CF survival over the decades, attributed to improvements in therapies available, our understanding of the disease and better organisation of care. CF care providers have been early advocates for successful healthcare transition from the paediatric to adult sector and CF can be considered a model process where a paediatric disease has now become an adult one. This article looks at the transition process in CF and the future challenges CF physicians will face.


  • Open Access

    Impact of 18F-FDG PET scan on the prevalence of benign thoracic lesions at surgical resection

    by Kamlesh Mohan, James McShane, Richard Page, Klaus Irion, Martin J. Ledson, Martin J. Walshaw

    OBJECTIVE: The main utility of 18-fluorodeoxyglucose positron emission tomography (FDG-PET) lies in the staging of lung cancer. However, it can also be used to differentiate indeterminate pulmonary lesions, but its impact on the resection of benign lesions at surgery is unknown. The aim of this study was to compare the prevalence of benign lesions at thoracotomy carried out for suspected lung cancer, before and after the introduction of PET scanning in a large thoracic surgical centre. MATERIALS AND METHODS: We reviewed our prospectively recorded surgical database for all consecutive patients undergoing thoracotomy for suspected or proven lung cancer and compared the prevalence of benign lesions in 2 consecutive 2-year groups, before (group I) and after (group II) the introduction of FDG-PET scan respectively. RESULTS: Surgical resection was performed on 1233 patients during the study period. The prevalence of benign lesions at surgery in groups I and II was similar (44/626 and 41/607, both 7%), and also in group II between those who underwent FDG-PET scan and the remainder (21/301 and 20/306 respectively, both 7%). In group II, of the 21 patients with benign lesions, who underwent FDG-PET, 19 had a false positive scan (mean standardised uptake value 5.3 [range 2.6-12.7]). Of these, 13 and 4 patients respectively had non-diagnostic bronchoscopy and percutaneous transthoracic lung biopsy pre thoracotomy. There was no difference in the proportion of different benign lesions resected between group I and those with FDG-PET in group II. CONCLUSION: The introduction of FDG-PET scanning has not altered the proportion of patients undergoing thoracotomy for ultimately benign lesions, mainly due to the avidity for the isotope of some non-malignant lesions. Such false positive results need to be considered when patients with unconfirmed lung cancer are contemplated for surgical resection.


  • Mechanisms of glucose intolerance in cystic fibrosis

    by K. Mohan, H. Miller, P. Dyce, R. Grainger, R. Hughes, J. Vora, M. Ledson, M. Walshaw

    Aims  Although cystic fibrosis‐related diabetes (CFRD), a poor prognostic factor in cystic fibrosis (CF), is characterized by insulinopenia, the role of insulin resistance is unclear. Using a prospective study design, we measured insulin resistance, pancreatic β‐cell function and correlated glycaemic status with clinical parameters.Methods  Oral glucose tolerance test was performed in 60 stable adult CF patients. Insulin sensitivity and β‐cell function were measured using the homeostatic model assessment (HOMA2), Stumvoll and oral glucose insulin sensitivity (OGIS) indices.Results  Forty‐two (70%) had normal glucose tolerance (NGT), 10 (17%) impaired glucose tolerance (IGT) and eight (13%) CFRD. There was no difference in insulin sensitivity among the three groups (HOMA2: NGT 280, IGT 250, CFRD 339, P = 0.42; Stumvoll: NGT 0.128, IGT 0.126, CFRD 0.129, P = 0.76; and OGIS: NGT 515, IGT 472, CFRD 472, P = 0.12). Pancreatic β‐cell function (CFRD 50% vs. NGT 67%; P < 0.05) and first‐phase insulin secretion were reduced in CFRD (250 vs. NGT 509; P = 0.004). First‐phase insulin secretion was inversely correlated with 1‐h (r = −0.74; P < 0.0001) and 2‐h glucose levels (r = −0.34; P < 0.05). There was no difference in body mass index or poor lung function (forced expiratory volume in 1 s: CFRD 54% vs. NGT 65%; P = 0.43). However, there were more hospital admissions in the CFRD group (three vs. NGT one per patient per year; P < 0.05).Conclusions  CFRD is characterized by qualitative and quantitative defects in insulin secretion, but not insulin resistance, and is associated with increased hospital admissions for pulmonary exacerbations.


  • Open Access

    Simultaneous bilateral spontaneous pneumothorax in an adult patient with cystic fibrosis

    by Kamlesh Mohan, Martin James Ledson, Martin John Walshaw, Edson Marchiori

    Pneumothorax is a common complication in cystic fibrosis and is associated with worsening of lung function. However, bilateral simultaneous pneumothorax in cystic fibrosis is a rare condition. We describe the case of a 17-year-old female with cystic fibrosis who presented with spontaneous pneumothorax. Clinically, she presented right-sided chest pain and progressive breathlessness. The pneumothorax failed to resolve after the initial treatment (chest drainage). However, the patient was later successfully treated with additional chest drainage and talc pleurodesis. We also discuss the etiology and management of pneumothorax in patients with cystic fibrosis, since pneumothorax is associated with increased morbidity and mortality among such patients.


  • Open Access

    Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain

    by Joanne L Fothergill, Stavroula Panagea, Charles A Hart, Martin J Walshaw, Tyrone L Pitt, Craig Winstanley

    Background: Some isolates of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa exhibit an unusual virulence-related phenotype, characterized by over-production of quorum sensing-regulated exoproducts such as pyocyanin and LasA protease. Our aim was to determine the prevalence of this unusual phenotype amongst isolates of the epidemic strain, and to study other intraclonal phenotypic and genotypic variations. Results: The unusual phenotype was detected in at least one epidemic strain isolate from the majority of cystic fibrosis patients tested, and can be retained for up to seven years during chronic infection. Multiple sequential isolates of the epidemic strain taken from six patients over a period of up to nine years exhibited a wide range of phenotypes, including different antimicrobial susceptibilities. Our data suggest that each sputum sample contains a mixture of phenotypes and genotypes within the epidemic strain population, including within colony morphotypes. Many isolates exhibit premature (during early rather than late exponential growth) and over-production of pyocyanin, which has a number of toxic effects directly relevant to cystic fibrosis. Conclusion: The widespread occurrence of this unusual phenotype suggests that it may play an important role in the success of the epidemic strain.


  • Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use

    by M. Al-Aloul, H. Miller, S. Alapati, P.A. Stockton, M.J. Ledson, M.J. Walshaw

    Although there are reports of cases of acute renal failure occurring in cystic fibrosis (CF) patients, usually in association with the use of nephrotoxic antibiotic therapy, there have been no studies of renal function in this patient group. We hypothesized that long‐term use of intravenous (IV) nephrotoxic antibiotics (aminoglycosides and colistin sulphomethate) may contribute to renal disease in CF patients. In a prospective study, we assessed creatinine clearance as an index of renal function with two techniques (24‐hr urine collections and the Cockroft‐Gault formula) in a group of 80 stable adult CF outpatients chronically infected with Pseudomonas aeruginosa but with no history of preceding renal disease. Using a multiple linear regression model, we evaluated their renal function in terms of their lifetime IV use of aminoglycosides and colistin. Between 31% (Cockroft‐Gault formula method) and 42% (24‐hr urine collection method) of patients had a creatinine clearance below normal range. Using either method, there was a strong correlation between aminoglycoside use and diminishing renal function (r = − 0.32, P = 0.0055), which was potentiated by the coadministration of colistin (r = − 0.42, P < 0.0002). However, there was no correlation with colistin when used in combination with other antibiotics alone (r = 0.18, P = NS). Repeated IV aminoglycoside use in CF is associated with long‐term renal damage. Although this effect is potentiated by colistin, colistin on its own in moderate doses does not appear to be nephrotoxic. IV aminoglycosides should be used cautiously in CF patients, with regular monitoring of renal function.